NewsRx

Search our medical news database

Therapy (HBV)

Lamivudine Active Against HBV in HIV+

Published in AIDS Weekly, December 23rd, 1996

The retroviral inhibitor lamivudine has been found active against hepatitis B virus replication in a group of men with HIV/HBV co-infection, but researchers warned that it is too early to call for its use in this group.

"Our study does not allow firm conclusions to be drawn because it was not designed to evaluate the efficacy of lamivudine against HBV infection, but our data indicate that lamivudine may have a role in HIV infected patients," research Yves Benhamou and colleagues from Paris' Hospitalier Pitie-Salpetriere wrote ("Effects of Lamivudine on Replication of Hepatitis B Virus in HIV Infected Men," Annals of Internal Medicine, November 1,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook